NantKwest Inc. (NK)
Symbol Info
Listed Symbol NK
Name NantKwest Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $47,000
Latest Fiscal EPS $-1.22
Price Info
21 Day Moving Average $1.2886
21 Day EMA $1.300450
50 Day Moving Average $1.2732
50 Day EMA $1.263910
200 Day EMA $1.521140
200 Day Moving Average 1.231500
52 Week High $4.23
52 Week Low $0.93
52 Week Change $-61.377197
Alpha -0.052449
Beta 2.3073
Standard Deviation 0.246411
R2 0.114423
Periods 50
Share Information
10 Day Average Volume 125,644
20 Day Average Volume 106,083
30 Day Average Volume 98,113
50 Day Average Volume 159,039
Outstanding Shares 98,307,859
Float Shares 93,789,465
Percent Float 95.40%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 141
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 1,442,136
Institute Holdings Percent 9.000000
Institute Sold Previous 3 Months 4,880,571
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 4,518,394
Price Change
7 Day Price Change $-0.0600001
7 Day Percent Change -4.44%
21 Day Price Change $-0.01
21 Day Percent Change -0.77%
30 Day Price Change $0.0200000
30 Day Percent Change 1.57%
Month To Date Price Change $-0.01
Month To Date Percent -0.77%
90 Day Price Change $0.190000
90 Day Percent Change 17.27%
Quarter To Date $0.270000
Quarter To Date Percent 26.47%
180 Day Price Change $-0.03
180 Day Percent Change -2.27%
200 Day Price Change $0.100000
200 Day Percent Change 8.40%
Year To Date $0.130000
Year To Date Percent 11.21%
Profile
Description NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories.
Details
Issue Type CS
Market Cap $126,817,138
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 98,307,859
CEO Patrick Soon-Shiong
Employees 151
Last Audit UQ
Classification
CIK 0001326110
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 3530 John Hopkins Court
San Diego, CA 92121
Website http://www.nantkwest.com
Facisimile
Telephone +1 858 633-0300
Email investors@nantkwest.com
Key Ratios
Profitability
EBIT Margin -125,891.7
EBITDA Margin -108,951.7
Pre-Tax Profit Margin -159,701.8
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $60,000
Revenue Per Share $0.0006
Revenue 3 Years $7.30
Revenue 5 Years $-40.04
Valuation Measures
PE Ratio -
Enterprise Value $56,779,059
Price To Sales 2,113.619000
Price To Free Cash -1.8
PE High Last 5 Years -
Price To Book 0.8
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 0.8
Financial Strength
Total Debt To Equity 0.1
Int Coverage -254.3
Current Ratio 7.0
Leverage Ratio 1.2
Quick Ratio 6.8
Long Term Debt To Capital 0.07
Assets
Receivables Turnover 0.1
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -39.57
Return On Equity -46.02
Return On Capital -42.51
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
NK
NantKwest
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.